Affiliation:
1. Lifespan and Population Health Academic Unit, School of Medicine, Nottingham City Hospital University of Nottingham Nottingham UK
2. Department of Respiratory Sciences University of Leicester Leicester UK
3. College of Population Health University of New Mexico Albuquerque New Mexico USA
Abstract
AbstractBackground and AimsAntimicrobial resistance (AMR) is among the top public health concerns around the globe. Migrants, especially forced migrants, could be at higher risk of acquiring and transmitting AMR during their journeys or in host countries. There is limited understanding regarding migrants' living conditions and the wider factors contributing to their risk of acquiring infections, and behaviors around antimicrobial use, and AMR development. In this study, we aimed to explore transit experiences, living conditions, and antibiotic use of migrants living in the United Kingdom.MethodsWe conducted semistructured qualitative interviews with 27 participants and identified five themes regarding migrants' journey and their living conditions during transit and after arriving in the United Kingdom, their access to water, sanitation and hygiene (WASH), and their use of antibiotics.ResultsMigrants, particularly forced migrants, experienced unfavorable living conditions, poor access to WASH, and challenges in accessing healthcare, which further contributed to health conditions like urinary and skin problems. Isolation and difficulty in accessing healthcare played significant roles in migrants' perceived need for storing and using antibiotics as a safety net.ConclusionThe findings highlight the need for coordinated and multilevel interventions to address these challenges and contribute toward tackling AMR and improving the health of this population group.
Reference43 articles.
1. Microbial Resistance Movements: An Overview of Global Public Health Threats Posed by Antimicrobial Resistance, and How Best to Counter
2. WHO Advisory Group on the R&D of Antibacterial Treatments. Pipeline of antibacterial products in clinical development.2022. [cited June 27 2022].https://www.who.int/observatories/global-observatory-on-health-research-and-development/monitoring/antibacterial-products-in-clinical-development-for-priority-pathogens
3. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
4. Antimicrobial Resistance and Human Mobility
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献